Litigation Details for NOVO NORDISK INC. v. SUN PHARMACEUTICAL INDUSTRIES LIMITED (D.N.J. 2015)
✉ Email this page to a colleague
NOVO NORDISK INC. v. SUN PHARMACEUTICAL INDUSTRIES LIMITED (D.N.J. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-02-11 |
| Court | District Court, D. New Jersey | Date Terminated | 2015-07-09 |
| Cause | 35:271 Patent Infringement | Assigned To | Michael Andre Shipp |
| Jury Demand | None | Referred To | Douglas Arpert |
| Patents | 7,018,992 | ||
| Firms | Fox Rothschild LLP, Pc | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in NOVO NORDISK INC. v. SUN PHARMACEUTICAL INDUSTRIES LIMITED
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for NOVO NORDISK INC. v. SUN PHARMACEUTICAL INDUSTRIES LIMITED (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-02-11 | 1 | the expiration of United States Patent No. 7,018,992 (“the ‘992 patent”), which covers, inter alia, a … COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 7,018,992 16. Plaintiffs re-allege… 1. This is an action for patent infringement under the patent laws of the United States, Title… THE PATENT-IN-SUIT 10. On March 28, 2006, the United States Patent and Trademark… of the ‘992 patent would infringe at least claims 7, 8, 9, 11, and 12 of the ‘992 patent under 35 U. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
